Insider Transactions Reported by 15 Insiders of PharmaCyte Biotech, Inc.

Symbol
PMCB on Nasdaq
Location
Las Vegas, NV

Insiders trading volume in the past year

PharmaCyte Biotech, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Joshua N. Silverman CEO and President, Director $397,694 +$80,476 +25% 05 Jan 2026
Jonathan Schechter Director $162,393 +$48,232 +42% 05 Jan 2026
Robert Weinstein Director $42,075 25 Apr 2025
Michael M. Abecassis Director $23,417 25 Apr 2025
Wayne R. Walker Director $21,037 25 Apr 2025
Carlos A. Trujillo Chief Financial Officer, Director 20 Nov 2023
Matthias Loehr Director 31 Mar 2022
Daniel Stuart Farb Director 28 Dec 2022
Daniel Allen Director 28 Dec 2022
Gerald W. Crabtree Chief Science Officer, Director 10 Aug 2021
Thomas C. K. Yuen Director 10 Aug 2021
Jack E. Stover Director 15 Aug 2022
Thomas Liquard Director 10 Aug 2021
Kenneth L. Waggoner Chairman, CEO, Pres and GC, Director 10 Aug 2021
Raymond Cf Tong Director 10 Aug 2021

Recent Insider Transactions by Companies or Individuals for PharmaCyte Biotech, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Joshua N. Silverman PMCB Common Stock Purchase 10.6% $33,316 $0.8329 40,000 416,250 07 Jan 2026 Direct
Jonathan Schechter PMCB Common Stock Purchase 11.6% $16,872 $0.8436 20,000 192,500 07 Jan 2026 Direct
Joshua N. Silverman PMCB Common Stock Purchase 8.66% $23,667 $0.7889 30,000 376,250 06 Jan 2026 Direct
Jonathan Schechter PMCB Common Stock Purchase 13.1% $15,808 $0.7904 20,000 172,500 06 Jan 2026 Direct
Joshua N. Silverman PMCB Common Stock Purchase 9.49% $23,493 $0.7831 30,000 346,250 05 Jan 2026 Direct
Jonathan Schechter PMCB Common Stock Purchase 15.1% $15,552 $0.7776 20,000 152,500 05 Jan 2026 Direct
Robert Weinstein PMCB Common Stock Tax liability -45% -33,750 41,250 12 Dec 2025 Direct
Robert Weinstein PMCB Common Stock Award 75,000 75,000 12 Dec 2025 Direct
Wayne R. Walker PMCB Common Stock Tax liability -45% -16,875 20,625 12 Dec 2025 Direct
Wayne R. Walker PMCB Common Stock Award 37,500 37,500 12 Dec 2025 Direct
Joshua N. Silverman PMCB Common Stock Tax liability -45% -258,750 316,250 12 Dec 2025 Direct
Joshua N. Silverman PMCB Common Stock Award 575,000 575,000 12 Dec 2025 Direct
Jonathan Schechter PMCB Common Stock Tax liability -33.8% -67,500 132,500 12 Dec 2025 Direct
Jonathan Schechter PMCB Common Stock Award 300% 150,000 200,000 12 Dec 2025 Direct
Michael M. Abecassis PMCB Common Stock Tax liability -43.1% -16,875 22,292 12 Dec 2025 Direct
Michael M. Abecassis PMCB Common Stock Award 2249.6% 37,500 39,167 12 Dec 2025 Direct
Robert Weinstein PMCB Stock Option (Right to Buy) Award 63,233 63,233 25 Apr 2025 Direct
Wayne R. Walker PMCB Stock Option (Right to Buy) Award 63,233 63,233 25 Apr 2025 Direct
Jonathan Schechter PMCB Stock Option (Right to Buy) Award 63,233 63,233 25 Apr 2025 Direct
Michael M. Abecassis PMCB Stock Option (Right to Buy) Award 63,233 63,233 25 Apr 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.